Patent Grant
10722154
This application is based on Japanese Patent Applications No. 2016-211013 filed on Oct. 27, 2016, the contents of which are incorporated herein by reference.
The presently disclosed subject matter relates to a medical photometer which calculates the amount of a material having a relatively low extinction in the body of the subject, and also to a method of controlling a medical photometer for calculating the amount of the material.
A pulse photometer that is an example of a medical photometer is an apparatus which calculates the concentration of a blood light absorber of the subject as an example of photometry.
Specifically, the living tissue of the subject is irradiated with light beams at a plurality of wavelengths at which ratios of the blood extinction coefficients are different from each other depending on the blood light absorber concentration. The intensities of the light beams at the wavelengths transmitted through or reflected from the living tissue are detected. The intensities at the wavelengths are varied in accordance with the pulsation of the blood in the subject. Therefore, due to the pulsation, temporal variations of the intensities at the wavelengths are acquired in the form of a pulse wave signal. The amplitudes of pulse wave signals with respect to wavelengths correspond to light attenuation variations with respect to the same wavelengths. The blood light absorber concentration is calculated based on a ratio of light attenuation variations with respect to wavelengths (for example, see Japanese Patent No. 4,196,209).
There is a need for knowing a thickness of a tissue including water or adipose among materials existing in the body of the subject. However, these materials have an extinction which, as compared with the above-described blood light absorbers, is lower over the whole wavelength range (for example, 190 to 1,100 nm) where a general-purpose optical sensor is sensitive. In the specification, such a material is referred to as “weak light absorber in body.”
It is an object of the presently disclosed subject matter to calculate the tissue thickness in body even with the principle of photometry.
On the other hand, a regular artifact of the subject may be recognized as a blood pulsation. Therefore, an accurate detection of the artifact of the subject is needed.
It is also an object of the presently disclosed subject matter to accurately detect an artifact of the living body which is one of causes of inhibition of the photometry.
According to an aspect of the presently disclosed subject matter, a medical photometer includes:
a first light emitter that emits a first light beam having a first wavelength;
a second light emitter that emits a second light beam having a second wavelength;
a detector that outputs a first intensity signal corresponding to an intensity of the first light beam that is transmitted through or reflected from a tissue of a living body, and a second intensity signal corresponding to an intensity of the second light beam that is transmitted through or reflected from the tissue;
a processor; and
a memory that stores an instruction that is readable by a computer,
wherein, when the instruction is executed by the processor, the medical photometer
both the first light beam and the second light beam are infrared light beams or red light beams,
a ratio of a first extinction of a first light absorber at the first wavelength and a second extinction of the first light absorber at the second wavelength is different from 1,
a third extinction of a second light absorber at the first wavelength is higher than the first extinction,
a fourth extinction of the second light absorber at the second wavelength is higher than the second extinction, and
a ratio of the third extinction and the fourth extinction is approximable by 1.
According to another aspect of the presently disclosed subject matter, a medical photometer includes:
a processor; and
a memory which stores an instruction that is readable by a computer,
wherein, when the instruction is executed by the processor, the medical photometer
a ratio of a first extinction of a first light absorber at the first wavelength and a second extinction of the first light absorber at the second wavelength is different from 1,
a third extinction of a second light absorber at the first wavelength is higher than the first extinction,
a fourth extinction of the second light absorber at the second wavelength is higher than the second extinction, and
a ratio of the third extinction and the fourth extinction is approximable by 1.
According to another aspect of the presently disclosed subject matter, a method of controlling a medical photometer includes:
causing the medical photometer to acquire a first light attenuation of a first light beam that has a first wavelength and that is transmitted through or reflected from a tissue of a living body, based on a first intensity signal corresponding to an intensity of the first light beam;
causing the medical photometer to acquire a second light attenuation of a second light beam that has a second wavelength and that is transmitted through or reflected from the tissue, based on a second intensity signal corresponding to an intensity of the second light beam;
causing the medical photometer to calculate a tissue thickness based on a ratio of the first light attenuation and the second light attenuation; and
causing the medical photometer to detect an artifact of the living body based on a temporal variation of the tissue thickness,
wherein a ratio of a first extinction of the first light absorber at the first wavelength and a second extinction of the first light absorber at the second wavelength is different from 1,
a third extinction of a second light absorber at the first wavelength is higher than the first extinction,
a fourth extinction of the second light absorber at the second wavelength is higher than the second extinction, and
a ratio of the third extinction and the fourth extinction is approximable by 1.
According to the above-described modes, while using the principle of photometry, the tissue thickness in body can be calculated. Further, an artifact of the living body which is one of causes of inhibition of the photometry can be correctly detected.
Hereinafter, embodiments will be described in detail with reference to the accompanying drawings.
The medical photometer 10 may include a first light emitter 11, a second light emitter 12, a detector 14, an interface 15, and a controller 16.
The first light emitter 11 is configured so as to emit a first light beam having a first wavelength λ1. The second light emitter 12 is configured so as to emit a second light beam having a second wavelength λ2. An example of the first wavelength λ1 is 880 nm. An example of the second wavelength λ2 is 940 nm. Namely, both the first and second light beams are infrared light beams.
For example, the first light emitter 11 is a semiconductor light emitting device which can emit the first light beam. For example, the second light emitter 12 is a semiconductor light emitting device which can emit the second light beam. Examples of such a semiconductor light emitting device are a light emitting diode (LED), a laser diode, and an organic electroluminescence element.
As shown in
The first light emitter 11, the second light emitter 12, and the detector 14 are connected to the interface 15. The interface 15 is a connector which allows signals to pass therethrough. The connection may be realized as wired or wireless connection.
The controller 16 is communicably connected to the first light emitter 11, the second light emitter 12, and the detector 14 through the interface 15. Therefore, the controller 16 can control the operations of the first light emitter 11 and the second light emitter 12 through the interface 15. The controller 16 can receive the first and second intensity signals from the detector 14 through the interface 15.
The controller 16 may include a processor 61 and a memory 62.
Examples of the processor 61 are a CPU and an MPU. The memory 62 is configured so as to store an instruction that is readable by a computer. Examples of the memory 62 are a ROM which stores various instructions, and a RAM having a work area in which various instructions are executed by the processor 61.
The medical photometer 10 is configured so as to execute the process shown in
A light attenuation (first light attenuation) A1 of the first light beam that is transmitted through or reflected from the living body 20 is acquired based on the first intensity signal supplied from the detector 14 (step S11).
The first light emitter 11 is controlled by the controller 16, and therefore the controller 16 already knows the intensity IO1 of the first light beam emitted from the first light emitter 11. Based on the intensity I1 of the first light beam which is detected by the detector 14, therefore, the first light attenuation A1 is acquired by the following expression:
A1ln(IO1/I1) (1)
Next, a light attenuation (second light attenuation) A2 of the second light beam that is transmitted through or reflected from the living body 20 is acquired based on the second intensity signal supplied from the detector 14 (step S12).
The second light emitter 12 is controlled by the controller 16, and therefore the controller 16 already knows the intensity IO2 of the second light beam emitted from the second light emitter 12. Based on the intensity I2 of the second light beam which is detected by the detector 14, therefore, the second light attenuation A2 is acquired by the following expression:
A2=ln(IO2/I2) (2)
Steps S11 and S12 may be performed in parallel, or step S12 may be performed in advance of step S11.
Then, the amount of the weak light absorber in the tissue of the living body 20 which the first and second light beams are transmitted through or reflected from is calculated based on the first and second light attenuations A1 and A2 which are acquired as described above (step S13).
In
As seen from the figure, the extinction (an example of the first extinction) of water at the first wavelength λ1 of the first light beam, and the extinction (an example of the second extinction) of water at the second wavelength λ2 of the second light beam are different from each other. In other words, a ratio of the extinction of water at the first wavelength λ1 and that of water at the second wavelength λ2 is different from 1. In the specification, the term “different from 1” means that the ratio has a value of 2 or larger, or 0.5 or smaller.
The extinction (an example of the third extinction) of hemoglobin at the first wavelength λ1 of the first light beam is higher than that of water at the same wavelength. Similarly, the extinction (an example of the fourth extinction) of hemoglobin at the second wavelength λ2 of the second light beam is higher than that of water at the same wavelength. In other words, the extinction of water is lower than that of hemoglobin at the first and second wavelengths λ1 and λ2. Namely, water is an example of the weak light absorber in body.
On the other hand, the extinction of hemoglobin at the first wavelength λ1 and that of hemoglobin at the second wavelength λ2 are substantially equal to each other. In other words, a ratio of the extinction of hemoglobin at the first wavelength λ1 and that of hemoglobin at the second wavelength λ2 can be approximated by 1. In the specification, the term “can be approximated by 1” means that the ratio has a value smaller than 2 or larger than 0.5.
In the embodiment, namely, the first and second wavelengths λ1 and λ2 are selected so that a weak light absorber in body (the first light absorber) the amount of which is to be specified has substantially different extinctions at λ1 and λ2, and that a light absorber (the second light absorber) which is higher in extinction than the weak light absorber in body shows substantially equal extinctions at λ1 and λ2.
The above-described first light attenuation A1 is the sum of the contribution of the light attenuation due to the first light absorber at the first wavelength λ1, and that of the light attenuation due to the second light absorber, and can be indicated by the following expression:
A1=E11C1D1+E21C2D2 (3)
where E11 indicates the extinction coefficient (M−1 cm−1) of the first light absorber at the first wavelength λ1, C1 indicates the concentration (M) of the first light absorber, D1 indicates the optical path length (cm) of a portion where extinction is performed by the first light absorber, E21 indicates the extinction coefficient (M−1 cm−1) of the second light absorber at the first wavelength λ1, C2 indicates the concentration (M) of the second light absorber, and D2 indicates the optical path length (cm) of a portion where extinction is performed by the second light absorber.
Same or similarly, the above-described second light attenuation A2 is the sum of the contribution of the light attenuation due to the first light absorber at the second wavelength λ2, and that of contribution of the light attenuation due to the second light absorber, and can be indicated by the following expression:
A2=E12C1D1+E22C2D2 (4)
where E12 indicates the extinction coefficient (M−1 cm−1) of the first light absorber at the second wavelength λ2, and E22 indicates the extinction coefficient (M−1 cm−1) of the second light absorber at the second wavelength λ2.
As described above, the contribution of the light attenuation due to the second light absorber at the first wavelength λ1, and that of the light attenuation due to the second light absorber at the second wavelength λ2 are substantially equal to each other. When the difference between the first light attenuation A1 and the second light attenuation A2 is obtained, therefore, the contribution of the light attenuation due to the second light absorber can be neglected, and only the contribution of the light attenuation due to the first light absorber can be extracted.
This fact is indicated with Expressions (1) to (4) as follows:
A1−A2=(E11C1D1+E21C2D2)−(E12C1D1+E22C2D2)
ln(IO1/I1)−ln(IO2/I2)≅(E11−E12)C1D1
ln(I2/I1)−ln(IO2/I01)≅(E11−E12)C1D1 (5)
In Expression (5), the second term of the left side is a ratio of the intensity of the first light beam emitted from the first light emitter 11, and that of the second light beam emitted from the second light emitter 12. As described above, these values are already known, and therefore the second term of the left side can be treated as a constant. On the other hand, also E11 and E12 in the right side are constants. Therefore, C1D1 can be specified from a ratio of the detected intensity of the first light beam by the detector 14, and that of the second light beam. This value corresponds to the amount of the first light absorber, i.e., the weak light absorber in body.
According to the technique of the embodiment, that is, the amount of the weak light absorber in body can be calculated even with the principle of photometry.
When a blood light absorber such as hemoglobin is selected as the second light absorber in the same manner as the embodiment, the first light attenuation A1 can be indicated more specifically by following expression as the sum of the contribution of the light attenuation due to the arterial blood at the first wavelength λ1, that of the light attenuation due to the venous blood, and that of the light attenuation due to tissues other than the blood:
A1=Ea1HbDa+Ev1HbDv+ΣEt1Dt (6)
where Ea1 indicates the extinction coefficient (dl g−1 cm−1) of hemoglobin in arterial blood at the first wavelength λ1, Hb indicates the hemoglobin concentration in blood (dl g−1), Da indicates the thickness (cm) of the blood vessel through which the arterial blood flows, Ev1 indicates the extinction coefficient (dl g−1 cm−1) of hemoglobin in venous blood at the first wavelength λ1, Dv indicates the thickness (cm) of the blood vessel through which the venous blood flows, Σt1 indicates the light attenuation rate (cm−1) due to tissues other than the blood at the first wavelength λ1, and Dt indicates the thickness (cm) of tissues other than the blood, i.e., the tissue thickness.
Same or similarly, the second light attenuation A2 can be indicated by the following expression as the sum of the contribution of the light attenuation due to the arterial blood at the second wavelength λ2, that of the light attenuation due to the venous blood, and that of contribution of the light attenuation due to tissues other than the blood, and can be indicated by the following expression:
A2=Ea2HbDa+Ev2HbDv+Σt2Dt (7)
where Ea2 indicates the extinction coefficient (dl g−1 cm−1) of hemoglobin in arterial blood at the second wavelength λ2, Ev2 indicates the extinction coefficient (dl g−1 cm−1) of hemoglobin in venous blood at the second wavelength λ2, and Σt2 indicates the light attenuation rate (cm−1) due to tissues other than the blood at the second wavelength λ2.
As described above, the contribution of the light attenuation due to hemoglobin at the first wavelength λ1, and that of the light attenuation due to hemoglobin at the second wavelength λ2 are substantially equal to each other. When the difference between the first light attenuation A1 and the second light attenuation A2 is obtained, therefore, the contribution of the light attenuation due to hemoglobin can be neglected, and only the contribution of the light attenuation due to the tissue thickness Dt can be extracted.
This fact is indicated with Expressions (1), (2), (6), and (7) as follows:
A1−A2=(Ea1HbDa+Ev1HbDv+Σt1Dt)−(Ea2HbDa+Ev2HbDv+Σt2Dt)
ln(IO1/I1)−ln(IO2/I2)≅(Σt1−Σt2))Dt
ln(I2/I1)−ln(IO2/I01)≅(Σt1−Σt2)Dt (8)
In Expression (8), the second term of the left side is a ratio of the intensity of the first light beam emitted from the first light emitter 11, and that of the second light beam emitted from the second light emitter 12. As described above, these values are already known, and therefore the second term of the left side can be treated as a constant. On the other hand, also Σt1 and Σt2 in the right side are constants. Therefore, the tissue thickness Dt can be specified from a ratio of the detected intensity of the first light beam by the detector 14, and that of the second light beam.
As an index indicating the degree of the blood circulation, the perfusion index is known. Even when the blood vessel pulsates at the same expansion rate, different perfusion indices may be acquired with photometry depending on the difference in tissue thickness. In the case of a subject having large fingers (the tissue thickness is large), the perfusion index generally tends to have a large value. In other words, when attention is focused only on the fact that the value of the perfusion index is small, it is not possible to accurately distinguish whether the fact is caused by insufficient perfusion of blood or by a small tissue thickness.
According to the configuration of the embodiment, the tissue thickness of the living body 20 can be specified with the principle of photometry, and therefore it is possible to provide information which can compensate insufficient information named the perfusion index. Consequently, the degree of the blood circulation in the living body 20 can be determined more accurately
As indicated by the broken line in
The third wavelength λ3 is selected as a wavelength which satisfies the following conditions.
In this case, the detector 14 is configured so as to output a third intensity signal in accordance with the intensity I3 of the third light beam that is transmitted through or reflected from the tissue of the living body 20.
In this case, the third light emitter 13 is connected to the interface 15. The connection may be realized as wired or wireless connection.
In this case, the controller 16 is communicably connected to the third light emitter 13 through the interface 15. Therefore, the controller 16 can control the operation of the third light emitter 13 through the interface 15. The controller 16 can receive the third intensity signal from the detector 14 through the interface 15.
In this case, when an instruction stored in the memory 62 is executed by the processor 61, the medical photometer 10 acquires a light attenuation variation ΔA3 of the third light beam due to the blood pulsation in the tissue (the place where the first and second light attenuations A1 and A2 are acquired) of the living body 20 based on the third intensity signal and at least one of the first and second intensity signals supplied from the detector 14. Then, a ratio of oxyhemoglobin to the amount of hemoglobin capable of carrying oxygen in the arterial blood, i.e., the arterial oxygen saturation (an example of the concentration of the second light absorber) is calculated based on the light attenuation variation λA3 of the third light beam and at least one of the acquired light attenuation variations λA1 and λA2 of the first and second light beams. The technique for calculating the arterial oxygen saturation with the principle of pulse photometry is well known, and therefore its detailed description is omitted.
According to the configuration, with the third light beam and at least one of the first and second light beams, the arterial oxygen saturation can be calculated with the principle of so-called pulse photometry. That is, the above-described configuration for specifying the amount of the weak light absorber in body can be integrated into a conventional probe which is to be used in pulse photometry. Namely, the user is allowed to easily calculate the amount of the weak light absorber in body and the arterial oxygen saturation, by simply attaching the probe to the tissue of the living body 20.
Referring to
Similarly with step S11 shown in
Similarly with step S12 shown in
Steps S21 and S22 may be performed in parallel, or step S22 may be performed in advance of step S21.
Then, the tissue thickness Dt of the living body 20 which the first and second light beams are transmitted through or reflected from is calculated based on the first and second light attenuations A1 and A2 that are acquired as described above (step S23). The calculation of the tissue thickness Dt is performed with Expressions (6) to (8) which have been described with reference to step S13 in
Then, an artifact of the living body 20 is detected based on a variation ΔDt of the tissue thickness Dt which is calculated in step S23 (step S24).
The tissue thickness Dt of the interested living body 20 is varied by an artifact of the living body 20. In the case where the tissue thickness is varied from Dt to (Dt+ΔDt) Expression (8) for obtaining the tissue thickness Dt can be transformed into the following manner. Here, the value (I2/I1) in Expression (8), i.e., the intensity ratio of the first and second light beams detected by the detector 14 is expressed as R, and the value (I02/I01) in Expression (8), i.e., the intensity ratio of the light beams emitted from the first and second light emitters 11 and 12 is expressed as RO. In this case, it is assumed that the value of the intensity ratio R is varied to (R+ΔR) by an artifact of the living body 20.
ln(R)−ln(RO)≅(Σt1−Σt2)Dt
ln(R+ΔR)−ln(RO)≅(Σt1−Σt2)(Dt+ΔDt)
ln(R+ΔR)−ln(R)≅(Σt1−Σt2)(Dt+ΔDt)−(Σt1−Σt2)Dt
ln[(R+ΔR)/R]≅(Σt1−Σt2)ΔDt
When it is assumed that ΔR is sufficiently smaller than R, the following expression is obtained:
ΔR/R≅(Σt1−Σt2)ΔDt (9)
It is seen that the variation rate (ΔR/R) of the intensity ratio is proportional to the variation ΔDt of the tissue thickness.
That is, the controller 16 monitors the temporal variation of the tissue thickness Dt by observing the temporal variation of the intensity ratio R of the first and second light beams detected by the detector 14. When a variation ΔR occurs in the intensity ratio R, it can be deemed that ΔDt is caused also in the tissue thickness Dt.
The lower left graph in
Although an extremely large artifact is indicated in the graph, there is a case where a variation of the detected intensity due to a relatively small artifact (particularly by a regular artifact) is hardly distinguished from that due to pulsation by simply monitoring the detected intensity of the first or second light beam.
By contrast, the upper left graph in
Namely, having the detector 14 detect a temporal variation of the intensity ratio R of the first and second light beams which corresponds to a temporal variation of the tissue thickness Dt, a variation of the detected intensity due to pulsation can be cancelled out, and a variation of the detected intensity due to an artifact can be more clearly extracted. This is because pulsation does not have a substantial influence on the tissue thickness Dt.
According to the configuration of the embodiment, therefore, the tissue thickness of a living body can be calculated with the principle of photometry, and moreover an artifact of the living body which is one of factors affecting the photometry can be accurately detected.
When the process of detecting an artifact is ended, it is determined whether the whole process is to be ended or not (step S25). If it is determined that the whole process is to be ended (YES in step S25), the whole process is ended. If it is determined that the whole process is not to be ended (NO in step S25), the process of detecting an artifact (step S24) is repeated.
As indicated by the broken line in
Specifically, the medical photometer 10 is configured so as to perform the processes indicated by the broken line in
When an artifact is detected in step S24, it is determined whether the degree of the artifact exceeds the predetermined value or not (step S26). The predetermined value is adequately adjustable by the user. Specifically, it is determined whether the variation rate of the intensity ratio R which is indicated in the upper left graph in
If it is determined that the degree of the detected artifact exceeds the predetermined value (YES in step S26), the notification is performed (step S27). As described above, the notification can be performed by at least one of visual notification and auditory notification. After the notification, the process is transferred to step S25, and the above-described processes are repeated.
If it is determined that the degree of the detected artifact is equal to or smaller than the predetermined value (NO in step S26), the process is transferred to step S25, and the above-described processes are repeated.
According to the configuration, the user is notified of an artifact of the living body 20 which may disturb the operation of the medical photometer 10, and thereby the user can take adequate procedures. When the predetermined value is properly set, it is possible to notify of only a situation where procedures must be truly taken. This can prevent the working efficiency of the user from being lowered.
As described in the first embodiment, the first light emitter 11, the second light emitter 12, and the detector 14 can be integrated into a conventional pulse photometry probe including the third light emitter 13.
In conventional pulse photometry, in order to avoid a situation where an artifact has an adverse influence on a calculated result of the arterial oxygen saturation, an independent sensor (such as an acceleration sensor) for detecting an artifact must be attached to the living body. In the embodiment, by contrast, a configuration for calculating the tissue thickness can be integrated into a probe for calculating the arterial oxygen saturation, and moreover an artifact can be detected with the probe. Therefore, a situation where an artifact has an adverse influence on a calculated result of the arterial oxygen saturation can be avoided without adding an independent sensor.
Referring to
The intensity of the first intensity signal corresponding to the intensity I1 of the first light beam which is emitted from the first light emitter 11 and detected by the detector 14 is acquired (step S31).
Next, the intensity of the second intensity signal corresponding to the intensity I2 of the second light beam which is emitted from the second light emitter 12 and detected by the detector 14 is acquired (step S32).
Steps S31 and S32 may be performed in parallel, or step S32 may be performed in advance of step S31.
Then, an intensity ratio which is a ratio of the intensity of the first intensity signal acquired in step S31, and that of the second intensity signal acquired in step S32 is obtained (step S33). The intensity ratio has a value corresponding to the intensity ratio R (=I2/I1) which has been described in the second embodiment.
When the temporal variation of the intensity ratio of the first and second intensity signals is monitored, therefore, an artifact of the living body 20 can be detected (step S34). At this time, the first wavelength λ1 and the second wavelength λ2 must be selected so as to enable the tissue thickness Dt to be calculated. However, the calculation of the tissue thickness Dt which has been described in the second embodiment is not essential.
According to the configuration, an artifact of the living body which is one of factors affecting the photometry can be accurately detected even with the principle of photometry.
When the process of detecting an artifact is ended, it is determined whether the whole process is to be ended or not (step S35). If it is determined that the whole process is to be ended (YES in step S35), the whole process is ended. If it is determined that the whole process is not to be ended (NO in step S35), the process of detecting an artifact (step S34) is repeated.
As an example of a technique for detecting an artifact, a coordinate plane P1 shown in the right half in
In the embodiment, an artifact of the living body 20 can be detected based on a temporal variation of a point in the coordinate plane P1, i.e., the shape of a locus (Lissajous figure) drawn by the point.
The upper right graph in
The lower right graph in
Such a Lissajous figure on the coordinate plane P1 can be displayed on a displaying section which is not shown. As compared with a simple display of a temporal variation of the intensity or the intensity ratio such as shown in the left half in
As indicated by the broken line in
As shown in
The Lissajous figure L1b which is formed in accordance with the artifact has a substantial width in both the directions of the abscissa and the ordinate. Therefore, the Lissajous figure L1b has a slope Ψ to the abscissa on the coordinate plane P1. In other words, the slope Ψ is an angle between the abscissa and the N axis corresponding to the noise component of the Lissajous figure L1b.
The coordinate transformation is performed so as to make the direction of the slope Ψ to coincide with the ordinate of the coordinate plane P2. As a result, a Lissajous figure L2 is obtained on the coordinate plane P2. In the Lissajous figure L2, the pulsation-contributed component and artifact-contributed component in the acquired first intensity signal are clearly separated from each other. When only the projection of the Lissajous figure L2 to the abscissa is extracted, therefore, the artifact-contributed component can be reduced from the first intensity signal, and only the pulsation-contributed component can be extracted.
As shown in
The intensity of the second intensity signal is selected as the abscissa of the coordinate plane, and similar processes are performed, whereby only the pulsation-contributed component of the acquired second intensity signal can be extracted.
A Lissajous figure L0 is formed in the thus configured coordinate plane P0. As seen from the figure, an S axis corresponding to the pulsation-contributed component (signal component), and an N axis corresponding to the artifact-contributed component (noise component) can be defined in the Lissajous figure L0. In order to finally obtain the Lissajous figure L2 on the coordinate plane P2 which is formed by the S and N orthogonal axes, therefore, it is required to consider both the coordinate transformation in which the S axis in the coordinate plane P0 is made to coincident with the abscissa in the coordinate plane P2, and that in which the N axis in the coordinate plane P0 is made to coincident with the ordinate in the coordinate plane P2.
In order to make the S axis in the coordinate plane P0 coincident with the abscissa in the coordinate plane P2, an angle ϕ between the S axis and the abscissa in the coordinate plane P0 must be specified. In the specification of the angle ϕ, information of the blood light absorber concentration is required both because the blood light absorber concentration is indicated as a function of the extinction ratio of the first and second light beams and because the extinction ratio is indicated as a function of the angle ϕ.
In order to make the N axis in the coordinate plane P0 coincident with the ordinate in the coordinate plane P2, an angle θ between the S axis and the N axis in the coordinate plane P0 must be specified. An angle Ψ between the N axis and the abscissa in the coordinate plane P0 is determined by searching the value of θ in the range from −ϕ to (π/2−ϕ), and by specifying a value at which the norm in the S-axis direction in the coordinate plane P2 is minimum. An angle ϕ is obtained by subtract θ from angle Ψ.
The coordinate transformation from the coordinate plane P0 to the coordinate plane P2 is performed with the thus specified values of ϕ and θ. The transformation technique is described in detail in Patent Literature 1, and therefore more detailed description is omitted here.
According to the technique of the embodiment shown in
As indicated by the broken line in
Specifically, the medical photometer 10 is configured so as to perform the processes indicated by the broken line in
When an artifact is detected in step S34, it is determined whether the degree of the artifact exceeds the predetermined value or not (step S37). The predetermined value is adequately adjustable by the user. Specifically, it is determined whether the width in the direction along the ordinate of the Lissajous
If it is determined that the degree of the detected artifact exceeds the predetermined value (YES in step S37), the notification is performed (step S38). As described above, the notification can be performed by at least one of visual notification and auditory notification. After the notification, the process is transferred to step S35, and the above-described processes are repeated.
If it is determined that the degree of the detected artifact is equal to or smaller than the predetermined value (NO in step S37), the process is transferred to step S36, and the above-described processes are repeated.
According to the configuration, the user is notified of an artifact of the living body 20 which may disturb the operation of the medical photometer 10, and thereby the user can take adequate procedures. When the predetermined value is properly set, it is possible to notify of only a situation where procedures must be truly taken. This can prevent the working efficiency of the user from being lowered.
As described in the first embodiment, the first light emitter 11, the second light emitter 12, and the detector 14 can be integrated into a conventional pulse photometry probe including the third light emitter 13.
In conventional pulse photometry, in order to avoid a situation where an artifact has an adverse influence on a calculated result of the arterial oxygen saturation, an independent sensor (such as an acceleration sensor) for detecting an artifact must be attached to the living body. In the embodiment, by contrast, a configuration for calculating the tissue thickness can be integrated into a probe for calculating the arterial oxygen saturation, and moreover an artifact can be detected with the probe. Therefore, a situation where an artifact has an adverse influence on a calculated result of the arterial oxygen saturation can be avoided without adding an independent sensor.
The above-described embodiments are mere examples for facilitating understanding of the presently disclosed subject matter. The configurations of the embodiments may be adequately changed or improved without departing from the spirit of the presently disclosed subject matter. It is obvious that equivalents are included within the technical scope of the presently disclosed subject matter.
In the above-described embodiments, both the first light beam emitted from the first light emitter 11, and the second light beam emitted from the second light emitter 12 are infrared light beams. However, a configuration where both the first and second light beams are red light beams may be employed. In this case, conditions are that the extinction of the weak light absorber in body at the first wavelength λ1 of the first light beam, and that of the weak light absorber in body at the second wavelength λ2 of the second light beam are substantially different from each other, and that a material which is higher in extinction than the weak light absorber in body has substantially equal extinctions at the first wavelength λ1 and the second wavelength λ2. In the case of water and hemoglobin shown in
In the above-described embodiments, the arterial oxygen saturation is used as an example of the blood light absorber concentration. However, the presently disclosed subject matter can be applied also to a configuration for calculating the concentration of another blood light absorber. Examples of another blood light absorber are carboxyhemoglobin, methemoglobin, and a dye injected into blood vessels. In this case, the wavelengths of the light beams are selected so that a ratio of the extinction coefficient of blood at these wavelengths is varied depending on the concentration of the target light absorber contained in the blood.
In the third embodiment which has been described with reference to
| Number | Date | Country | Kind |
|---|---|---|---|
| 2016-211013 | Oct 2016 | JP | national |
| Number | Name | Date | Kind |
|---|---|---|---|
| 5002391 | Wolfrum | Mar 1991 | A |
| 5385143 | Aoyagi | Jan 1995 | A |
| 5490505 | Diab | Feb 1996 | A |
| 5588427 | Tien | Dec 1996 | A |
| 5632272 | Diab | May 1997 | A |
| 6002952 | Diab | Dec 1999 | A |
| 8560034 | Diab | Oct 2013 | B1 |
| 10342465 | Ueda | Jul 2019 | B2 |
| 20020035315 | Ali | Mar 2002 | A1 |
| 20030009090 | Jeon | Jan 2003 | A1 |
| 20030133538 | Herve | Jul 2003 | A1 |
| 20040267140 | Ito et al. | Dec 2004 | A1 |
| 20050065415 | Cho et al. | Mar 2005 | A1 |
| 20080139908 | Kurth | Jun 2008 | A1 |
| 20090290148 | Kawanishi | Nov 2009 | A1 |
| 20120232365 | Ukawa | Sep 2012 | A1 |
| 20140247274 | Nagata | Sep 2014 | A1 |
| 20150272488 | Ueda | Oct 2015 | A1 |
| 20170303788 | Xavier Da Silveira | Oct 2017 | A1 |
| 20180116567 | Ueda | May 2018 | A1 |
| 20180116569 | Ueda | May 2018 | A1 |
| 20190083016 | Ueda | Mar 2019 | A1 |
| 20190090745 | Konno | Mar 2019 | A1 |
| Number | Date | Country |
|---|---|---|
| 4196209 | Dec 2008 | JP |
| Entry |
|---|
| Communication dated Feb. 8, 2018, from the European Patent Office in counterpart European Application No. 17198546.8. |
| Number | Date | Country | |
|---|---|---|---|
| 20180116568 A1 | May 2018 | US |
